Amphotericin B liposomal
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Empiric therapy for presumed fungal infection in patients with febrile neutropenia
- Visceral leishmaniasis
NON-FDA APPROVED USES
- Zygomycetes and other invasive molds
- Coccidioidomycosis
- Histoplasmosis
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Empiric therapy for presumed fungal infection in patients with febrile neutropenia
- Visceral leishmaniasis
NON-FDA APPROVED USES
- Zygomycetes and other invasive molds
- Coccidioidomycosis
- Histoplasmosis
There's more to see -- the rest of this entry is available only to subscribers.